AbbVie
ABBV
About AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque…
ABBV Key Financials
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
ABBV Analysis Tools & Insights
Revenue Counter
Earns $1,992 every second. See per minute, hour, and day.
Earnings Counter
Earns $115.39 per second net profit. See per minute, hour, and day.
Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
What If Invested
What if you had invested $1,000? See historical returns from any date.
How it makes money
Discover visual breakdown of $62.82B in revenue — where it comes from and where it goes.
Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
Price target scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
Daily Price Character
Steady · 53.6% historical win rate (green days). Streaks & record days.
Buybacks
0.39% TTM buyback yield. Shareholder yield & SBC comparison.
Dividend Profile
Yield: 2.97%. Safety: 4/8. See full history.
Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.
Dividend Capture
Historical pre-ex touch stats, gap distribution, after-tax calculator, and a backtest simulator (limit-order vs MOC exit).